Innate Pharma to hold its annual general meeting of shareholders on May 21, 2026
Number of shares and voting rights of Innate Pharma as of April 9, 2026
Innate Pharma to present at the AACR 2026 Oncology Industry Partnering Event
Innate Pharma to participate in the Kempen Life Sciences conference
Innate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) And 2025 Form 20-f Annual Report
Innate Pharma reports full year 2025 financial results and business update
Innate Pharma announces conference call and webcast for full year 2025 financial results
Number of shares and voting rights of Innate Pharma as of February 19, 2026
Innate pharma to participate in the Leerink Partners Global Healthcare Conference
Number of shares and voting rights of Innate Pharma as of December 31, 2025
